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We previously established a human T cell line, TPA-Mat, which can proliferate in response to not only interleukin-2 
(IL-2), but also phorbol esters such as 12-0-tetradecanoylphorbol-13-acetate (TPA) and phorbol-12,13-dibutyrate 
(PDBu). The present study demonstrated that the PDBu-dependent growth of TPA-Mat cells was inhibited up to 90% 
by adenosine 3’,5’-cyclic monophosphate (CAMP)) raising agents such as forskolin, cholera toxin and 1-methyl-3-isobutyl- 
xanthine, and CAMP analogues, whereas the IL-2-stimulated TPA-Mat growth was slightly inhibited. These findings sug- 
gest that the signal transduction pathway of PDBu-induced growth, which should involve activation of protein kinase 
C, is sensitive to CAMP, and that it cannot be exactly identical to the signal transduction pathway of 11-2-induced growth 
in TPA-Mat cells. 
cyclic AMP; Protein kinase C: Interleukin-2 
1. INTRODUCTION 
TXe l’nt’eractitin or“ Z-2 wiiil ii%- ;ligk &ini~~7- 
receptor has been shown to transduce the growth 
signal, although the mechanism of intracellular 
gr cow?n r;l_n ;iGns ‘1s s$G urixnDxn, ‘h ‘nas ‘Deen 3%~ - 
gest& that IL-2 stirnutats t~m0x~ 0f PI, whkh 
results in activation of PKC [1,2]. We have recent- 
ly established a TPA-dependent cell line (TPA- 
Mat) from an IL-2-dependent human T cell line 
(ILT-Mat) [3]. TPA-Mat cells can proliferate 
dependent on IL-2 and various PKC activators 
such as TPA, PDBu, teleocidin and apliciatoxin. 
This suggests that PKC plays an important role in 
growth signaling. So far, two major classes of 
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receptors transducing intracellular signals across 
the membrane have been identified. One class 
rq#ati- &iPiF am? L&- cnikr rcguiZ05 ~I.mnrvn- 
of PI, which generates diacylglycerol and 
inositol-1,4,5trisphosphate, as second messengers 
) P e_j,ew >qjl. Tnt 5>aLq&tm& -~~~~%x~~Y-YG, -an& 
inv+&i- < ;4,5 -&isphwq+Z& Increases i1%ltra&l&X 
free Ca2+ [5,6]. CAMP and PI turnover appear to 
antagonize each other in signal transduction in 
most tissues [5]. In lymphocytes, CAMP has been 
shown to inhibit PI turnover and thereby suppress 
the activation of PKC [7]. However, the effect of 
CAMP on the signal transduction following PKC 
activation is unknown. Therefore, we examined 
the effects of CAMP on cell growth signalings in- 
duced by IL-2 and PDBu, and demonstrated that 
CAMP significantly inhibits PDBu-induced signal 
transduction in TPA-Mat cells. 
2.1. Cell culture 
TTZ-~-?~MC c&s were mktdm& ‘m part ‘RI mwhr n&irum 
(RPM1 1640 medium supplemented with 10% fetal calf serum) 
containing 100 ng/ml of PDBu, and in part in growth medium 
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containing 200 U/ml of human recombinant IL-2 (obtained 
from Shionogi Co., Osaka, Japan) at 37°C with 7% CO2 in air. 
2.2. Incorporation of [3Hjthymidine (TdRj 
[3H]TdR incorporation assays were carried out as described 
PI. 
2.3. Cyclic AMP measurement 
TPA-Mat cells were washed twice with growth medium, and 
plated into culture plates (Terumo, SH-TJZFSW) at 1.0 x 
106/ml. 1OOpM of IBMX was added to each well, and the 
plates were incubated for 30 min at 37°C prior to addition of 
forskolin. After 5 min incubation with forskolin at various con- 
centrations, an equal volume of chilled 12% trichloroacetic acid 
was added to each well. After standing overnight at 4”C, the 
trichloroacetic acid-extractant was centrifuged at 1500 x g at 
4°C for 30 min. Trichloroacetic acid in the supernatant was ex- 
tracted twice with 2 ml of diethyl ether saturated with distilled 
water, and the extracted solution was used for the CAMP assay. 
CAMP content was measured by the radioimmunoassay method 
with a Yamasa CAMP assay kit as reported by Honma et al. [9]. 
3. RESULTS 
The growth of TPA-Mat cells was stimulated by 
PDBu and by IL-2 in a dose-dependent manner 
(fig.1). PDBu-stimulated TPA-Mat growth was in- 
hibited up to 90% in the presence of 10~M for- 
skolin. In contrast, IL-2-stimulated TPA-Mat 
growth was slightly inhibited by forskolin (fig.1). 
Similar results to the above were obtained in three 
experiments. The inhibitory effect of forskolin on 
TPA-Mat growth is quantitatively shown in fig.2. 
IL-2-stimulated TPA-Mat growth was weakly af- 
fected by forskolin even at a concentration of 
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Fig. 1. Effects of forskolin on PDBu- or IL-2-dependent growth 
of TPA-Mat cells. TPA-Mat cells were incubated for 48 h in a 
growth medium containing the indicated doses of PDBu or IL-2 
in the presence (0) or absence (0) of 1OpM forskolin. During 
the last 4 h of incubation, [3H]TdR was added, and the 
[jH]TdR incorporated was measured. 
166 
Forskolin ( PM 1 
Fig.2. Dose response of forskolin for inhibition of TPA-Mat 
cell growth. TPA-Mat cells were incubated for 48 h in a growth 
medium containing 100 ng/ml of PDBu (0) or 200 U/ml of 
IL-2 (0) in the presence of the indicated doses of forskolin. 
During the last 4 h of incubation, [‘H]TdR was added, and the 
[3H]TdR incorporated was measured. 
30 PM, whereas PDBu-stimulated TPA-Mat 
growth was remarkably inhibited by forskolin in a 
dose-dependent manner. Inhibitions of PDBu- 
Forskolin ( PM ) 
Fig.3. Intracellular CAMP levels of TPA-Mat cells cultured with 
PDBu or IL-2. TPA-Mat cells cultured with PDBu (0) or IL-2 
(0) were treated with IBMX for 30 min and then with 
forskolin for 5 min. They were extracted with trichloroacetic 
acid, and used for the CAMP assay as described in section 2. 
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Table 1 
Effects of CAMP analogues or CAMP-raising reagents on the 
growth of TPA-Mat cells 
Treatecb W’Sn 
Maintained with: 
PDBu IL-2 
PDBu or IL-2 alone 100 100 
+ db-CAMP (300 PM) 22.1 88.1 
+ 8b-CAMP (300 PM) 41.2 70.1 
+ IBMX (100 (tM) 33.7 76.6 
+ cholera toxin (100 ng/ml) 11.6 81.6 
+ forskolin (10 PM) 15.4 71.5 
Untreated 0.6 0.6 
TPM-Mat cells were maintained in a growth medium containing 
PDBu or IL-2. They were then examined for [jH]TdR 
incorporation under the indicated treatment 
dependent growth of about 90% and 50% were ob- 
tained wirh >%-?&,_& ans1 >,_& of Eo&xo3m, 
respectively. To determine whether the striking dif- 
ference in sensitivity to forskolin was due to the 
degree of CAMP production in TPA-Mat cells, we 
measured intracetiular cAWrP ‘rev& after treat- 
ment with forskolin in both PDBu- and 
IL-2-stimulated TPA-Mat cells. Fig.3 shows that 
intracc&u>ar c?G+Y jevds were s&ni!i~canYi~ arm 
dose-dependently elevated by forskolin under both 
culture conditions, and the elevated CAMP levels 
did not change during at least 48 h cultivation after 
forskolin treatment. 
We ‘rhen jnves%galeh Yne e%ecls 03 orher G&Y? 
raisirg agents or CAMP analogues on PDBu- x3r 
IL-a-stimulated TPA-Mat growth. db-CAMP and 
8b-CAMP are CAMP analogues, IBMX is a CAMP 
phosphodiesterase inhibitor, and cholera toxin is 
an adenylate cyclase activator. All the reagents had 
similar effects on TPA-Mat growth (table 1). 
4. DISCUSSION 
We showed that CAMP did not inhibit 
IL-2-depe&eR.? gr@.V& af a TPcZ-@r PDBar_ 
dependent human T cell line (TPA-Mat), but did 
inhitit PDBu-dependent growth oE it. The TPA- 
Mat, which was established from an 
IL-2-f!qxnik~~ hwxU T neU h-is!, h!& t,!x .%!Mity 
to proliferate dependent on various MC ac- 
tivators such as TPA, PDBu, teleocidin, mezerein 
and apliciatoxin [3]. All the PKC activators are 
known to bind to PKC directly and to activate it 
[5,10,11]. Thus the growth signaling induced by 
PDBu in TPA-Mat cells could be due to PKC ac- 
%va%Dn. The ;DJEBsenl s1xb jnfiralen Zhal &Z&Y 
blocked the transduction pathway of the growth 
signal induced by PDBu in TPA-Mat cells. The an- 
tagonistic interaction between PKC and CAMP- 
dependent protein kinase, PKA, has been reported 
in various cells in relation to some signal transduc- 
tion systems (review [12]). In peripheral lym- 
phocytes, CAMP is known to Hock PI turnover, 
which suppresses the activation of PKC [7]. The 
present data may provide a new insight into the an- 
tagonistic interaction between PKA and PKC in 
the signal transduction pathway of cell growth. In 
contrast to PDBu-stimulated growth, IL-2-stimu- 
lated growth of TPA-Mat cells was slightly in- 
hibited by CAMP. These different effects of CAMP 
are not due to the difference in the rate of genera- 
$103 or hgra~ahon of s9WZ? berween PDBU- anB 
IL-Zstimulated TPA-Mat cells, since there are no 
significant differences in intracellular CAMP levels 
between them at various times of treatment with 
forskoiin. Therefore, the fotiowing explanation 
for the different effects of CAMP on growth of 
TPA-Mat cells can be proposed: the growth signal 
jnbnceb br X-2 may be ‘rransmmeb nol only &on. 
the CAMP-sensitive pathway, where the PKC ac- 
tivation may be involved, but also along the 
CAMP-insensitive pathway, where PKC activation 
may not be involved. 
We recenYI_v esrab5jsheb a unjqne cesS Yme, CT - 
Mar., derived from ILT-Mar. The growfh of CT- 
Mat cells is sustained by cholera toxin instead of by 
IL-2, and the cholera toxin-mediated growth signal 
does not seem to be transmitted through PKC ac- 
tivation (Takeshita, T. et al., in preparation). Fur- 
thermore, it has been reported that IL-2 induces 
generation of CAMP but not of inositol phosphates 
in activated human T cells [13]. Together with the 
present study, these data suggest hat the growth 
signaling from the IL-2 receptor may be mediated 
hy a p&z&Vay wh&h .&&es Z&o.? &Y&e PKC. 
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